4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-24-026397
President & CEO sold 5,000 shares at $51.63 ($258,150)
- President & CEO acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Blum Robert I · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $6.67 | $33,350 | 402,456 | D |
| 2024-11-01 | Sale : show line 2 in the form 10b5-1 | −5,000 | $51.63 | $258,150 | 397,456 | D |
| Open-market sales · 5,000 sh · avg $51.63 · $258,150 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-01 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −5,000 | 64,727 | D |
Loading xslF345X05/form4.xml…